Sildenafil, a novel effective oral therapy for male erectile dysfunction

British Journal of Urology

Volumn 78, Issue 2, 1996, Pages 257-261

  Boolell, M ^a,b   Gepi Attee, S ^a   Gingell, J C ^a   Allen, M J ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Penile plethysmography; Pentile erection; Sildenafil

Indexed keywords

CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PLACEBO; SILDENAFIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS CAVERNOSUM; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ENZYME ACTIVITY; HEADACHE; HUMAN; IMPOTENCE; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; PELVIS PAIN SYNDROME; PENIS ERECTION; PLETHYSMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VISUAL STIMULATION;

EID: 0030438222     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1996.10220.x     Document Type: Article

References (21)

1. Impotence. National Institute of Health Consensus Development Panel on Impotence Conference. JAMA 1993; 270: 83-90
2. Kinsey AC, Pomeroy WB, Martin CE. Sexual behaviour in the human male. Philadelphia: WB Saunders, 1948
3. Felfman HA, Goldstein I, Hatzichriston DG, Krane RJ, McKinlay JU. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Ageing Study. J Urol 1994; 151: 54-61
4. Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. New Engl J Med 1989; 321: 1648-59
5. Kim N, Azadzoi KM, Goldstein I, Saenz de Tejada I. A nitric oxide-like factor mediates non-adrenergic -noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle. J Clin Invest 1991; 88: 112-8
6. Bush PA, Aronson WJ, Raifer J, Ignarro LJ. The L-argininenitric oxide-cyclic GMP pathway mediates inhibitory nonadrenergic-non-cholinergic neurotransmission in the corpus cavernosum of human and rabbit. Circ 1993; 87 (suppl v): V30-2
7. Saenz de Tejada I, Goldstein I, Blanco R, Cohen RA, Krane RJ. Smooth muscle of the corpora cavernosae: role in penile erection. Surg Forum 1985; 36: 623-4
8. Aboseif SR, Lue TF. Haemodynamics of penile erection. Urol Clin North Am 1988; 15: 1-7
9. Bain CL, Guary AT. Reproducibility in monitoring nocturnal penile tumescence of rigidity. J Urol 1992; 148: 811-4
10. Burris AS, Banks SM, Sherins RJ. Quantitative assessment of nocturnal penile tumescence and rigidity in normal men using a home monitor. J Androl 1989; 10: 492-7
11. Mainland D. Elementary Medical Statistics. Philadelphia: WB Saunders, 1963
12. Gart JJ. An exact test for comparing matched proportions in crossover designs. Biometrika 1969; 56: 75-80
13. Riley AJ, Goodman RE, Kellett JM. Orr R. Double blind trial of yohimbine hydrocholoride in the treament of erection inadequacy. J Sex Marital Ther 1989; 4: 17-26
14. Morales A, Surridge DHC, Marshall PG, Fenemore J. Nonhormonal pharmacological treatment of organic impotence. J Urol 1982; 12: 45-7
15. Grégoire A. New treatments for erectile impotence. Br ] Psychiat 1992; 160: 315-26
16. Virag R. Intracavenous injection of papaverine for erectile failure. Lancet 1982; 2: 938
17. Levine SB, Althof SE, Turner LA. Risen CB, Bodner DR, Kursh ED, Resnik MI. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J Urol 1989; 141: 54-7
18. Padma-Nathan H. Goldstein I, Payton T, Krane RJ. Intracavernosal pharmacotherapy: the pharmacologie erection program. World] Urol 1987; 5: 160-5
19. Porst H. Diagnostic use and side effects of vasoactive drugs: a report on over 2100 patients with erectile failure. Int J Impotence Res 1990; 2 (suppl 2): 222-3
20. Allen RP, Smolev JK, Engel RM, Brendler CB. Comparison of RigiScan and formal nocturnal penile tumescence testing in the evaluation of erectile rigidity. J Urol 1993; 149: 1265-8
21. Weinberg TJ, Badlani GH. Utility of RigiScan and papaverine in the diagnosis of erectile impotence. Urology 1988: 31: 526-9